文献速递心境障碍

重度抑郁症非典型特征与肥胖相关免疫代谢失调的遗传关联

Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

结果发现A/W增加亚组与BMI存在强正遗传相关,而A/W减少亚组与BMI呈反向相关且具有更高的BMI、CRP和瘦素多基因风险。提示非典型抑郁症状与肥胖相关特征的关联可能源于共享的病理生理机制。

要点

  • MDD伴食欲/体重增加亚组与BMI遗传相关为0.53(SE 0.15;P=6.3×10⁻⁴)。
  • A/W减少亚组与BMI遗传相关为-0.28(SE 0.14;P=.06),呈反向趋势。
  • A/W减少亚组BMI多基因风险OR=1.18(95%CI 1.12-1.25;P=1.6×10⁻¹⁰)。

核心结论

  • 非典型抑郁症状与肥胖相关特征的表型关联可能源于MDD患者共享的病理生理机制。
  • 针对免疫代谢失调开发有效治疗可能使抑郁合并肥胖患者获益。

研究设计与样本

  • 多中心研究整合精神病学基因组学联盟14个数据集的全基因组基因型和表型数据。
  • MDD按DSM-IV食欲/体重症状变化分为减少和增加两个亚组。

主要发现

  • MDD患者中5347例(45.2%)归入A/W减少亚组,1871例(15.8%)归入A/W增加亚组。
  • 常见遗传变异在两个亚组中解释约10%的遗传力。
  • A/W增加亚组与BMI呈强正遗传相关(0.53[0.15];P=6.3×10⁻⁴)。
  • A/W减少亚组与BMI呈反向相关(-0.28[0.14];P=.06)。
  • A/W减少亚组BMI多基因风险OR=1.18(95%CI 1.12-1.25;P=1.6×10⁻¹⁰),CRP多基因风险OR=1.08(95%CI 1.02-1.13;P=7.3×10⁻³),瘦素多基因风险OR=1.09(95%CI 1.06-1.12;P=1.7×10⁻³)。

关键数值与推荐

  • 采用结构化诊断工具依据DSM-IV诊断终生MDD。
  • 按DSM-IV食欲/体重症状变化将MDD患者分为减少或增加亚组。

临床怎么用

  • 临床评估MDD时应关注食欲/体重变化特征,以识别不同免疫代谢风险亚型。
  • 对伴肥胖相关特征的抑郁患者,可考虑免疫代谢通路作为潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. OBJECTIVE: To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). DESIGN, SETTING, AND PATIENTS: This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. MAIN OUTCOMES AND MEASURES: Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased. RESULTS: Data included 11 837 participants with MDD and 14 791 control individuals, for a total of 26 628 participants (59.1% female and 40.9% male). Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation (SE) with BMI (0.53 [0.15]; P = 6.3 × 10-4), whereas the decreased A/W subgroup showed an inverse correlation (-0.28 [0.14]; P = .06). Furthermore, the decreased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18; 95% CI, 1.12-1.25; P = 1.6 × 10-10) and levels of CRP (OR, 1.08; 95% CI, 1.02-1.13; P = 7.3 × 10-3) and leptin (OR, 1.09; 95% CI, 1.06-1.12; P = 1.7 × 10-3). CONCLUSIONS AND RELEVANCE: The phenotypic associations between atypical depressive symptoms and obesity-related traits may arise from shared pathophysiologic mechanisms in patients with MDD. Development of treatments effectively targeting immunometabolic dysregulations may benefit patients with depression and obesity, both syndromes with important disability.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Milaneschi Y, Lamers F, Peyrot WJ, et al. Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations. JAMA Psychiatry. 2017. PMID: 29049554. doi:10.1001/jamapsychiatry.2017.3016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。